Pharmacological inhibition of the chemokine receptor CX3CR1 attenuates disease in a chronic-relapsing rat model for multiple sclerosis. Ridderstad Wollberg A, Ericsson-Dahlstrand A, Juréus A, Ekerot P, Simon S, Nilsson M, Wiklund S-J, Berg A-L, Ferm M, Sunnemark D, et al. Proc Natl Acad Sci U S A. 2014 Apr 8; 111(14):5409-14. Epub 2014 Mar 25. PMID: 24706865. Abstract CommentRecommendBookmarkWatch